FindTrial
Sign In

A study to identify SARS-CoV-2 in Red Blood Cells in infected patients.

A study to identify SARS-CoV-2 in erythrocytes of patients suffering from COVID-19 at an Apex tertiary care institute in Andhra Pradesh, South India. - 19CoVRBC

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/01/030630
Enrollment
10
Registered
2021-01-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

All India Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: COVID-19 Positive by RT-PCR

Exclusion criteria

Exclusion criteria: 1.Negative for COVID-19 illness 2.Not willing to participate in the study 3.Age 55 years 4.Prisoners 5.Pregnant women 6.Severely ill patients

Design outcomes

Primary

MeasureTime frame
Detection of COVID-19 RNA in RBC/Blood samples during active infectionTimepoint: immediately at enrolment considered Day1—

Secondary

MeasureTime frame
DETECTION OF COVID-19 RNA IN RBC/BLOOD SAMPLES PLASMA OR LEUKOREDUCTIONTimepoint: AFTER CENTRIFUGATION AFTER 3RD WASH AFTER 6TH WASH AFTER LEUKOREDUCTION—

Countries

India

Contacts

Public ContactDr I S Chaitanya Kumar

Faculty at AIIMS, Mangalagiri

ischaitanyakumar@gmail.com9440106689

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026